HOUSE AMENDMENT |
Bill No. SB 2322 |
|
|
|
|
1
|
CHAMBER ACTION |
2
|
|
3
|
. |
4
|
. |
5
|
. |
6
|
|
7
|
|
8
|
|
9
|
|
10
|
|
11
|
|
12
|
Representative Green, Gelber, and Goodlette offered the |
13
|
following: |
14
|
|
15
|
Amendment (with title amendment) |
16
|
On page 3, line 10, through page 6, line 9, |
17
|
remove: all of said lines |
18
|
|
19
|
and insert: manufacturers and consumer advocates, develop a |
20
|
uniform application form to be completed by seniors who wish to |
21
|
participate in the Sunshine for Seniors Program.
|
22
|
(c) May request proposals from application assistance |
23
|
organizations to assist eligible individuals with obtaining |
24
|
prescription drugs through manufacturers' pharmaceutical |
25
|
assistance programs.
|
26
|
(d) Shall train volunteers to help eligible individuals |
27
|
fill out applications for the manufacturers' pharmaceutical |
28
|
assistance programs.
|
29
|
(e) Shall train volunteers to determine when applicants |
30
|
may be eligible for other state programs and refer them to the |
31
|
proper entity for eligibility determination for such programs.
|
32
|
(f) Shall seek federal funds to help fund the Sunshine for |
33
|
Seniors Program.
|
34
|
(g) May seek federal waivers to help fund the Sunshine for |
35
|
Seniors Program.
|
36
|
(6) COMMUNITY PARTNERSHIPS.--The Department of Elderly |
37
|
Affairs may build private sector and public sector partnerships |
38
|
with corporations, hospitals, physicians, pharmacists, |
39
|
foundations, volunteers, state agencies, community groups, area |
40
|
agencies on aging, and any other entities that will further the |
41
|
intent of this section. These community partnerships may also be |
42
|
used to facilitate other pro bono benefits for eligible |
43
|
individuals, including, but not limited to, medical, dental, and |
44
|
prescription services.
|
45
|
(7) CONTRACTS.--The Department of Elderly Affairs may |
46
|
select and contract with application assistance organizations to |
47
|
assist eligible individuals in obtaining their prescription |
48
|
drugs through the manufacturers' pharmaceutical assistance |
49
|
programs. If the department contracts with an application |
50
|
assistance organization, the department shall evaluate quarterly |
51
|
the performance of the application assistance organization to |
52
|
ensure compliance with the contract and the quality of service |
53
|
provided to eligible individuals.
|
54
|
(8) REPORTS AND EVALUATIONS.--By January 1 of each year, |
55
|
while the Sunshine for Seniors Program is operating, the |
56
|
Department of Elderly Affairs shall report to the Legislature |
57
|
regarding the implementation and operation of the Sunshine for |
58
|
Seniors Program.
|
59
|
(9) NONENTITLEMENT.--The Sunshine for Seniors Program |
60
|
established by this section is not an entitlement. If funds are |
61
|
insufficient to assist all eligible individuals, the Department |
62
|
of Elderly Affairs may develop a waiting list prioritized by |
63
|
application date.
|
64
|
Section 2. The sum of $226,660 is appropriated from the |
65
|
General Revenue Fund to the Department of Elderly Affairs, and |
66
|
one position is authorized, to implement section 1 of this act |
67
|
during the 2003-2004 fiscal year.
|
68
|
Section 3. Subsection (2) of section 409.904, Florida |
69
|
Statutes, is amended to read: |
70
|
409.904 Optional payments for eligible persons.--The |
71
|
agency may make payments for medical assistance and related |
72
|
services on behalf of the following persons who are determined |
73
|
to be eligible subject to the income, assets, and categorical |
74
|
eligibility tests set forth in federal and state law. Payment |
75
|
on behalf of these Medicaid eligible persons is subject to the |
76
|
availability of moneys and any limitations established by the |
77
|
General Appropriations Act or chapter 216. |
78
|
(2) A caretaker relative or parent, a pregnant woman, a |
79
|
child under age 19 who would otherwise qualify for Florida |
80
|
Kidcare Medicaid, a child up to age 21 who would otherwise |
81
|
qualify under s. 409.903(1), a person age 65 or over, or a blind |
82
|
or disabled person, who would otherwise be eligible for Florida |
83
|
Medicaid, except that the income or assets of such family or |
84
|
person exceed established limitations. For a family or person in |
85
|
one of these coverage groups, medical expenses are deductible |
86
|
from income in accordance with federal requirements in order to |
87
|
make a determination of eligibility. Expenses used to meet |
88
|
spend-down liability are not reimbursable by Medicaid. Effective |
89
|
JulyMay1, 2003, when determining the eligibility of a pregnant |
90
|
woman, a child, or an aged, blind, or disabled individual, $270 |
91
|
shall be deducted from the countable income of the filing unit. |
92
|
When determining the eligibility of the parent or caretaker |
93
|
relative as defined by Title XIX of the Social Security Act, the |
94
|
additional income disregard of $270 does not apply. A family or |
95
|
person eligible under the coverage known as the "medically |
96
|
needy," is eligible to receive the same services as other |
97
|
Medicaid recipients, with the exception of services in skilled |
98
|
nursing facilities and intermediate care facilities for the |
99
|
developmentally disabled. |
100
|
Section 4. The nonrecurring sums of $8,265,777 from the |
101
|
General Revenue Fund, $2,505,224 from the Grants and Donations |
102
|
Trust Fund, and $11,727,287 from the Medical Care Trust Fund are |
103
|
appropriated to the Agency for Health Care Administration to |
104
|
implement section 3 of this act during the 2002-2003 fiscal |
105
|
year. |
106
|
Section 5. Effective July 1, 2003, section 409.9065, |
107
|
Florida Statutes, is amended to read: |
108
|
409.9065 Pharmaceutical expense assistance.-- |
109
|
(1) PROGRAM ESTABLISHED.--There is established a program |
110
|
to provide pharmaceutical expense assistance to eligiblecertain |
111
|
low-income elderly individuals, which shall be known as the "Ron |
112
|
Silver Senior Drug Program" and may be referred to as the |
113
|
"Silver Lifesaver Program." |
114
|
(2) ELIGIBILITY.--Eligibility for the program is limited |
115
|
to those individuals who qualify for limited assistance under |
116
|
the Florida Medicaid program as a result of being dually |
117
|
eligible for both Medicare and Medicaid, but whose limited |
118
|
assistance or Medicare coverage does not include any pharmacy |
119
|
benefit. To the extent funds are appropriated, specifically |
120
|
eligible individuals are individuals who: |
121
|
(a) Are Florida residents age 65 and over; |
122
|
(b) Have an income equal to or less than 200 percent of |
123
|
the federal poverty level;: |
124
|
1. Between 88 and 120 percent of the federal poverty |
125
|
level;
|
126
|
2. Between 88 and 150 percent of the federal poverty level |
127
|
if the Federal Government increases the federal Medicaid match |
128
|
for persons between 100 and 150 percent of the federal poverty |
129
|
level; or
|
130
|
3. Between 88 percent of the federal poverty level and a |
131
|
level that can be supported with funds provided in the General |
132
|
Appropriations Act for the program offered under this section |
133
|
along with federal matching funds approved by the Federal |
134
|
Government under a s. 1115 waiver. The agency is authorized to |
135
|
submit and implement a federal waiver pursuant to this |
136
|
subparagraph. The agency shall design a pharmacy benefit that |
137
|
includes annual per-member benefit limits and cost-sharing |
138
|
provisions and limits enrollment to available appropriations and |
139
|
matching federal funds. Prior to implementing this program, the |
140
|
agency must submit a budget amendment pursuant to chapter 216;
|
141
|
(c) Are eligible for both Medicare and Medicaid; |
142
|
(d) Have exhausted pharmacy benefits under Medicare, |
143
|
Medicaid, or any other insurance planAre not enrolled in a |
144
|
Medicare health maintenance organization that provides a |
145
|
pharmacy benefit; and |
146
|
(e) Request to be enrolled in the program. |
147
|
(3) BENEFITS.--Eligible individuals shall receive a |
148
|
discount for prescription drugsMedications covered under the |
149
|
pharmaceutical expense assistance program are those covered |
150
|
under the Medicaid program in s. 409.906(20)(19). Monthly |
151
|
benefit payments shall be limited to $80 per program |
152
|
participant. Participants are required to make a 10-percent |
153
|
coinsurance payment for each prescription purchased through this |
154
|
program. |
155
|
(a) Eligible individuals with incomes equal to or less |
156
|
than 120 percent of the federal poverty level shall receive a |
157
|
discount of 100 percent for the first $160 worth of prescription |
158
|
drugs they receive each month, subject to copayments that the |
159
|
agency requires on these benefits. For all other prescription |
160
|
drugs received each month, eligible individuals shall receive a |
161
|
discount of 50 percent. |
162
|
(b) Eligible individuals with incomes of more than 120 |
163
|
percent but not more than 150 percent of the federal poverty |
164
|
level shall receive a discount of 50 percent. |
165
|
(c) Eligible individuals with incomes of more than 150 |
166
|
percent but not more than 175 percent of the federal poverty |
167
|
level shall receive a discount of 41 percent.
|
168
|
(d) Eligible individuals with incomes of more than 175 |
169
|
percent but not more than 200 percent of the federal poverty |
170
|
level shall receive a discount of 37 percent.
|
171
|
(4) ADMINISTRATION.--The pharmaceutical expense assistance |
172
|
program shall be administered by the agency for Health Care |
173
|
Administration, in collaborationconsultationwith the |
174
|
Department of Elderly Affairs and the Department of Children and |
175
|
Family Services. |
176
|
(a) The Agency for Health Care Administration and the |
177
|
Department of Elderly Affairs shall develop a single-page |
178
|
application for the pharmaceutical expense assistance program.
|
179
|
(a)(b) The agency for Health Care Administrationshall, by |
180
|
rule, establish for the pharmaceutical expense assistance |
181
|
program eligibility requirements;, limits on participation;, |
182
|
benefit limitations, including copayments;a requirement for |
183
|
generic drug substitution;,and other program parameters |
184
|
comparable to those of the Medicaid program. However, there |
185
|
shall be no monetary limit on prescription drugs purchased with |
186
|
discounts of less than 51 percent unless the agency determines |
187
|
there is a risk of a funding shortfall in the program. If the |
188
|
agency determines there is a risk of a funding shortfall, the |
189
|
agency may establish monetary limits on prescription drugs which |
190
|
shall not be less than $160 worth of prescription drugs per |
191
|
month. |
192
|
(b)(c) By January 1 of each year, the agency for Health |
193
|
Care Administrationshall report to the Legislature on the |
194
|
operation of the program. The report shall include information |
195
|
on the number of individuals served, use rates, and expenditures |
196
|
under the program. The report shall also address the impact of |
197
|
the program on reducing unmet pharmaceutical drug needs among |
198
|
the elderly and recommend programmatic changes. |
199
|
(5) NONENTITLEMENT.--The pharmaceutical expense assistance |
200
|
program established by this section is not an entitlement. |
201
|
Enrollment levels are limited to those authorized by the |
202
|
Legislature in the annual General Appropriations Act. If, after |
203
|
establishing monetary limits as required by paragraph (4)(a), |
204
|
funds are insufficient to serve all eligible individuals |
205
|
eligible under subsection (2) andseeking coverage, the agency |
206
|
may develop a waiting list based on application dates to use in |
207
|
enrolling individuals in unfilled enrollment slots. |
208
|
(6) PHARMACEUTICAL MANUFACTURER PARTICIPATION.--In order |
209
|
for a drug product to be covered under Medicaid or this program, |
210
|
the product's manufacturer shall: |
211
|
(a) Provide a rebate to the state equal to the rebate |
212
|
required by the Medicaid program; and |
213
|
(b) Make the drug product available to the program for the |
214
|
best price that the manufacturer makes the drug product |
215
|
available in the Medicaid program. |
216
|
(7) REIMBURSEMENT.--Totalreimbursements to pharmacies |
217
|
participating in the pharmaceutical expense assistance program |
218
|
established under this section shall be equivalent to |
219
|
reimbursements under the Medicaid program. |
220
|
(8) FEDERAL APPROVAL.--The benefits provided in this |
221
|
section are limited to those approved by the Federal Government |
222
|
pursuant to a Medicaid waiver or an amendment to the state |
223
|
Medicaid plan.
|
224
|
Section 6. This act shall take effect upon becoming a law, |
225
|
unless otherwise specified in this act, but if it becomes a law |
226
|
after May 1, 2003, sections 3 and 4 of this act shall operate |
227
|
retroactively to that date. |
228
|
|
229
|
================= T I T L E A M E N D M E N T ================= |
230
|
On page 1, line 23, |
231
|
remove: all of said line |
232
|
|
233
|
and insert: application; amending s. 409.9065, F.S.; adding |
234
|
eligibility groups; providing benefits; providing collaboration |
235
|
with the Department of Children and Family Services; requiring |
236
|
federal approval of benefits; providing effective dates. |